NCT00317538View on ClinicalTrials.gov

Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to Etanercept

PHASE3CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

June 30, 2003

Study Completion Date

November 30, 2004

Conditions
Rheumatoid Arthritis
Interventions
DRUG

infliximab, etanercept

All Listed Sponsors
lead

Centocor Ortho Biotech Services, L.L.C.

INDUSTRY

NCT00317538 - Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to Etanercept | Biotech Hunter | Biotech Hunter